Influence Of Eudragit RSPO And Polycaprolactone On The Release Rate And In Vitro Evaluation In The Formulation Of Sustained Release Orlistat Matrix Microparticles. Journal of Pharmaceutical Negative Results [Internet]. 2022 Nov. 5 [cited 2025 Oct. 29];:1271-84. Available from: https://mail.pnrjournal.com/index.php/home/article/view/2951